Sign In

Login

Password

Forgot Password ? Sign Up

Foscarnet (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Foscarnet" in Italian language version.

refsWebsite
Global rank Italian rank
19nih.gov
4th place
9th place
2oadoi.org
799th place
22nd place
2doi.org
2nd place
7th place
1fda.gov
447th place
644th place

doi.org (Global: 2nd place; Italian: 7th place)

dx.doi.org

fda.gov (Global: 447th place; Italian: 644th place)

nih.gov (Global: 4th place; Italian: 9th place)

ncbi.nlm.nih.gov

  • B. Oberg, Antiviral effects of phosphonoformate (PFA, foscarnet sodium)., in Pharmacol Ther, vol. 19, n. 3, 1982, pp. 387-415, PMID 6201932.
  • EG. Sandstrom, JC. Kaplan; RE. Byington; MS. Hirsch, Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate., in Lancet, vol. 1, n. 8444, Giu 1985, pp. 1480-2, PMID 2409414.
  • O. Ringdén, B. Lönnqvist; T. Paulin; J. Ahlmén; G. Klintmalm; B. Wahren; JO. Lernestedt, Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients., in J Antimicrob Chemother, vol. 17, n. 3, Mar 1986, pp. 373-87, PMID 3009383.
  • CS. Crumpacker, Mechanism of action of foscarnet against viral polymerases., in Am J Med, vol. 92, 2A, Feb 1992, pp. 3S-7S, PMID 1371038.
  • PS. Lietman, Clinical pharmacology: foscarnet., in Am J Med, vol. 92, 2A, Feb 1992, pp. 8S-11S, PMID 1371039.
  • P. Bonnafous, L. Naesens; S. Petrella; A. Gautheret-Dejean; D. Boutolleau; W. Sougakoff; H. Agut, Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet., in Antivir Ther, vol. 12, n. 6, 2007, pp. 877-88, PMID 17926642.
  • EP. Tchesnokov, C. Gilbert; G. Boivin; M. Götte, Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet., in J Virol, vol. 80, n. 3, Feb 2006, pp. 1440-50, DOI:10.1128/JVI.80.3.1440-1450.2006, PMID 16415021.
  • F. Aweeka, J. Gambertoglio; J. Mills; MA. Jacobson, Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis., in Antimicrobial Agents and Chemotherapy, vol. 33, n. 5, Mag 1989, pp. 742-5, PMID 2546491.
  • P. Chrisp, SP. Clissold, Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis., in Drugs, vol. 41, n. 1, Gen 1991, pp. 104-29, PMID 1706982.
  • AJ. Wagstaff, HM. Bryson, Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections., in Drugs, vol. 48, n. 2, Ago 1994, pp. 199-226, PMID 7527325.
  • MA. Jacobson, JJ. O'Donnell, Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet., in J Acquir Immune Defic Syndr, 4 Suppl 1, 1991, pp. S11-5, PMID 1848616.
  • MA. Jacobson, Foscarnet therapy for AIDS-related opportunistic herpesvirus infections., in AIDS Clin Rev, 1992, pp. 173-89, PMID 1318736.
  • A. Canestri, J. Ghosn; M. Wirden; F. Marguet; N. Ktorza; I. Boubezari; S. Dominguez; P. Bossi; E. Caumes; V. Calvez; C. Katlama, Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance., in Antivir Ther, vol. 11, n. 5, 2006, pp. 561-6, PMID 16964823.
  • S. Mathiesen, E. Dam; B. Roge; LB. Joergensen; AL. Laursen; J. Gerstoft; F. Clavel, Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1., in Antivir Ther, vol. 12, n. 3, 2007, pp. 335-43, PMID 17591023.
  • PR. Meyer, W. Rutvisuttinunt; SE. Matsuura; AG. So; WA. Scott, Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet., in J Mol Biol, vol. 369, n. 1, Mag 2007, pp. 41-54, DOI:10.1016/j.jmb.2007.03.006, PMID 17400246.
  • MA. Jacobson, Review of the toxicities of foscarnet., in J Acquir Immune Defic Syndr, 5 Suppl 1, 1992, pp. S11-7, PMID 1534839.
  • BN. Becker, G. Schulman, Nephrotoxicity of antiviral therapies., in Curr Opin Nephrol Hypertens, vol. 5, n. 4, Lug 1996, pp. 375-9, PMID 8823538.
  • A. Schwarz, A. Perez-Canto, Nephrotoxicity of antiinfective drugs., in Int J Clin Pharmacol Ther, vol. 36, n. 3, Mar 1998, pp. 164-7, PMID 9562233.
  • R. Sannerstedt, P. Lundborg; BR. Danielsson; I. Kihlström; G. Alván; B. Prame; E. Ridley, Drugs during pregnancy: an issue of risk classification and information to prescribers., in Drug Saf, vol. 14, n. 2, Feb 1996, pp. 69-77, PMID 8852521.

oadoi.org (Global: 799th place; Italian: 22nd place)